Blog Band - Page 268 of 269

Insights+: An Analysis of Biopharma Companies Growth in Last 20 Years (1999-2018)

In the last 20 years the global Biopharma space has changed a lot with ups and downs of companies and their growth. This analysis has found the multiple acquisitions and mergers along with the launch of several blockbusters leading to jump in growth and revenue of numerous companies. Pfizer acquired Warner-Lambert in 2000 to gain…

BySenior EditorJune 19, 20190Comments

TOP 20

Top 20 Medical Device Companies Based on 2018 Revenue

The Medical device market is growing with greater needs of patients and with their emerging diseases. 2018 has shown major advancement in medical device needs and upgrades with 55 novel drug approvals. The year 2018 has shown a slight change in the ledger of top 20 firms while Medtronic holds its first position with a…

ByPrince GiriJune 6, 20190Comments

INSIGHTS+

Insights+ Key Biosimilars Events of May 2019

Biosimilars are going in market with vast emerging needs of people for multiple diseases. The biologics that are too costly to be used in the markets. Hence physicians are developing biosimilars a reference product to biologics which are biologically similar to biologics. Our team at PharmaShots have summarized some of the news regarding biosimilars in…

BySenior EditorJune 4, 20190Comments

TOP 20

Top 10 Oncology Companies By 2018 Revenue

The Pharma companies focusing on oncology has been emerging in market with greater needs of people suffering from Cancer. The sales of oncology drugs gradually increasing with diseases. The top oncology companies are now developing more advanced- effective- and tolerable drugs to improve treatment outcomes and the patient experience. Roche proved to be on top…

ByPrince GiriMay 31, 20190Comments

INSIGHTS+

Insights+: Breakthrough Therapy Designation by the US FDA in 2018

Breakthrough Therapy (BT) Designation is an expedited review program introduced in Section 902 of the Food and Drug Safety and Innovation Act of 2012. The Breakthrough Designation is granted to the drugs as monotherapy or in combination with other drugs intended to treat serious or life-threatening diseases and has shown substantial improvement over available therapies…

BySenior EditorMay 8, 20190Comments

TOP 20

Top 20 BioPharma Companies based on 2018 Total Revenue

The global pharma companies have been advancing their pipelines with emerging needs of patients. Pharma companies are also focusing on diagnostics & devices- which were emerged as one of major revenue generator in 2018- with the development of new products and devices. The year 2018 also proved to be a record with approval of 55…

ByPrince GiriMay 1, 20190Comments

INSIGHTS+

PharmaShots Awarded as Feedspot’s Top 50 Pharma Blog

Shots: Team PharmaShots proudly announce that we are awarded as Top 50 Pharma Blog by Feedspot We are thankful to Feedspot for identifying our efforts and awarding us with this honor. We will continue to put our effort to provide the latest news available to our subscribers PharmaShots, a Division of Octavus Consulting, which provides real-time summarized…

BySenior EditorMarch 13, 20191Comment

INSIGHTS+

Insights+: The US FDA New Drug Approvals in 2018

1. Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC) Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC 2. Helsinn's (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV) Published: 14 Feb,2018 | Tags: Helsins, fosnetupitant + palonosetron, Receives, FDA, Approval, Managing Chemotherapy-Induced Nausea and Vomiting,…

BySenior EditorMarch 4, 20190Comments

INSIGHTS+

PharmaShots Year in Review: Biosimilars Approvals in 2018

THE US FDA APPROVALS 1. Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia Published: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia 2. Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval for Neutropenia Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the US FDA 3. Sandoz's Hymiroz (adalimumab-adaz, biosimilar) Receives the US FDA…

BySaurabh ChaubeyJanuary 8, 20190Comments

Insights+: An Analysis of Biopharma Companies Growth in Last 20 Years (1999-2018)

Top 20 Medical Device Companies Based on 2018 Revenue

Insights+ Key Biosimilars Events of May 2019

Top 10 Oncology Companies By 2018 Revenue

Insights+: Breakthrough Therapy Designation by the US FDA in 2018

Top 20 BioPharma Companies based on 2018 Total Revenue

PharmaShots Awarded as Feedspot’s Top 50 Pharma Blog

Insights+: The US FDA New Drug Approvals in 2018

PharmaShots Year in Review: Biosimilars Approvals in 2018

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter